Marinomed Biotech Stock Forecast - Naive Prediction

Marinomed Biotech Additional Predictive Modules

Most predictive techniques to examine Marinomed price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Marinomed using various technical indicators. When you analyze Marinomed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur. A naive forecasting model for Marinomed Biotech is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Marinomed Biotech AG value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Marinomed Biotech Naive Prediction Price Forecast For the 24th of January

Given 90 days horizon, the Naive Prediction forecasted value of Marinomed Biotech AG on the next trading day is expected to be 19.30 with a mean absolute deviation of 0.18, mean absolute percentage error of 0.05, and the sum of the absolute errors of 10.71.

Marinomed Biotech Stock Forecast Pattern

Backtest Marinomed Biotech

Marinomed Biotech Price Prediction

Buy or Sell Advice

Marinomed Biotech Forecasted Value

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Marinomed Biotech stock data series using in forecasting. Note that when a statistical model is used to represent Marinomed Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. This model is not at all useful as a medium-long range forecasting tool of Marinomed Biotech AG. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Marinomed Biotech. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Marinomed Biotech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Marinomed Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 17.71 19.00 20.29 Details

Intrinsic Valuation Low Real High 14.92 16.21 20.90 Details

Bollinger Band Projection (param) Low Middle High 18.40 18.97 19.54 Details

Marinomed Biotech After-Hype Price Prediction Density Analysis

Marinomed Biotech Estimiated After-Hype Price Volatility

Marinomed Biotech Stock Price Prediction Analysis

Marinomed Biotech Hype Timeline

Marinomed Biotech is now traded for 19.00on Vienna Exchange of Austria. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Marinomed is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at -0.11%. %. The volatility of related hype on Marinomed Biotech is about 0.0%, with the expected price after the next announcement by competition of 19.00. About 38.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 4.0. Marinomed Biotech had not issued any dividends in recent years. Assuming the 90 days trading horizon the next forecasted press release will be uncertain. Check out Historical Fundamental Analysis of Marinomed Biotech to cross-verify your projections.

Marinomed Biotech Related Hype Analysis

Other Forecasting Options for Marinomed Biotech

For every potential investor in Marinomed, whether a beginner or expert, Marinomed Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Marinomed Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Marinomed. Basic forecasting techniques help filter out the noise by identifying Marinomed Biotech's price trends.

Marinomed Biotech Related Equities

Risk & Return

Correlation

Marinomed Biotech Market Strength Events

Marinomed Biotech Risk Indicators

Story Coverage note for Marinomed Biotech

Other Macroaxis Stories

Other Information on Investing in Marinomed Stock